切换至 "中华医学电子期刊资源库"

中华肺部疾病杂志(电子版) ›› 2024, Vol. 17 ›› Issue (05) : 773 -776. doi: 10.3877/cma.j.issn.1674-6902.2024.05.018

临床研究

慢性阻塞性肺疾病真菌感染风险早期预测分析
王石林1,(), 叶继章1, 丘向艳1, 陈桂青1, 邹晓敏1   
  1. 1.516001 惠州,惠州市中心人民医院老年科
  • 收稿日期:2024-06-08 出版日期:2024-10-25
  • 通信作者: 王石林

Early prediction of fungal infection risk in chronic obstructive pulmonary disease

Shilin Wang(), Jizhang Ye, Xiangyan Qiu, Guiqing Chen, Xiaomin Zou   

  • Received:2024-06-08 Published:2024-10-25
  • Corresponding author: Shilin Wang
引用本文:

王石林, 叶继章, 丘向艳, 陈桂青, 邹晓敏. 慢性阻塞性肺疾病真菌感染风险早期预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 773-776.

Shilin Wang, Jizhang Ye, Xiangyan Qiu, Guiqing Chen, Xiaomin Zou. Early prediction of fungal infection risk in chronic obstructive pulmonary disease[J/OL]. Chinese Journal of Lung Diseases(Electronic Edition), 2024, 17(05): 773-776.

目的

分析慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)真菌感染风险的预测。

方法

选取2022 年1 月至2023 年12 月我院收治的58 例COPD 患者为对象,真菌感染21 例为观察组,未感染真菌37 例为对照组,比较两组患者基线资料,采用Logistic 回归分析影响COPD 患者真菌感染风险的危险因素,构建预测模型。

结果

观察组入院时血糖(11.75±1.42)mmol/l、血清降钙素原(procalcitonin, PCT)(2.74±0.47)ng/ml、C 反应蛋白(C-reactive protein, CRP)(17.13±2.58)mg/l、低蛋白血症13 例(61.90%)、入院前3 个月内使用抗生素9 例(42.86%)、抗生素使用时间≥14 d 15 例(71.43%)高于对照组入院时血糖(9.01±1.19)mmol/l、血清降钙素原(procalcitonin, PCT)(2.42±0.72)ng/ml、C 反应蛋白(C-reactive protein, CRP)(15.62±3.38)mg/l、低蛋白血症5 例(13.51%)、入院前3 个月使用抗生素4 例(10.81%)、抗生素使用≥14 d 6 例(16.22%)(P<0.05)。 多因素Logistic 回归分析显示,入院时血糖(OR=5.375;P=0.001)、低蛋白血症(OR=10.508;P=0.014)、入院前3 个月使用抗生素(OR=13.521;P=0.029)、抗生素使用≥14 d(OR=11.379;P=0.013)为COPD 真菌感染的危险因素。 建立预测COPD 真菌感染风险的列线图模型,校准曲线显示与实际曲线拟合度高。

结论

入院时血糖、低白蛋白血症、入院前3 个月使用抗生素和/或抗生素使用≥14 d 可早期预测COPD 合并真菌感染的危险因素。

表1 两组COPD 患者临床资料结果比较[n(%)]
表2 COPD 并发真菌感染多因素Logistic 回归分析
图1 预测COPD 患者真菌感染风险度
1
Rahi MS, Thilagar B, Balaji S, et al. The impact of anxiety and depression in chronic obstructive pulmonary disease[J]. Adv Respir Med, 2023, 91(2): 123-134.
2
任成山, 王关嵩, 钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
3
Halpin DMG, Criner GJ, Papi A, et al. Global initiative for the diagnosis, management, and prevention of chronic obstructive lung disease. the 2020 GOLD science committee report on COVID-19 and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(1): 24-36.
4
Schiebler ML,Seo JB. Artificial intelligence analysis of bronchiectasis is predictive of outcomes in chronic obstructive pulmonary disease[J]. Radiology, 2023, 307(1): e222675.
5
Su YC, Jalalvand F, Thegerström J, et al. The interplay between immune response and bacterial infection in COPD: focus upon nontypeable haemophilus influenzae[J]. Front Immunol, 2018, 9:2530.
6
Claassen-Weitz S, Lim KYL, Mullally C, et al.The association between bacteria colonizing the upper respiratory tract and lower respiratory tract infection in young children:a systematic review and meta-analysis[J].Clin Microbiol Infect,2021,27(9):1262-1270.
7
Khawaja F, Chemaly RF. Predicting risk of progression to lower respiratory tract infection in allogeneic hematopoietic cell transplant recipients with respiratory viral infections: where are we now? [J].Bone Marrow Transplant, 2022, 57(5): 701-702.
8
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021 年修订版)[J]. 中华结核和呼吸杂志,2021, 44(3): 170-205.
9
中华医学会呼吸病学分会. 中国成人社区获得性肺炎诊断和治疗指南(2016 年版)[J]. 中华结核和呼吸杂志, 2016, 39(4):253-279.
10
Kelly BT, Pennington KM, Limper AH. Advances in the diagnosis of fungal pneumonias[J]. Expert Rev Respir Med, 2020, 14(7):703-714.
11
Tiew PY, Thng KX, Chotirmall SH. Clinical aspergillus signatures in COPD and bronchiectasis[J]. J Fungi (Basel), 2022, 8(5):480.
12
Deolmi M, Decarolis NM, Motta M, et al. Early origins of chronic obstructive pulmonary disease: prenatal and early life risk factors[J]. Int J Environ Res Public Health, 2023, 20(3): 2294.
13
Short B, Delaney C, Johnston W, et al. Informed development of a multi-species biofilm in chronic obstructive pulmonary disease[J].APMIS, 2024, 132(5): 336-347.
14
Lindemann-Perez E,Perez JC. Candida albicans natural diversity:a resource to dissect fungal commensalism and pathogenesis[J]. Curr Opin Microbiol, 2024, 80: 102493.
15
Khandelwal A, Chaudhary SC, Verma AK, et al. Nontubercular bacterial and fungal infections in patients of chronic obstructive pulmonary disease[J]. Ann Afr Med, 2023, 22(1): 77-81.
16
Ren X,Liu W,Liu Y. Effects of fluconazole on the clinical outcome and immune response in fungal co-infected tuberculosis patients[J].Microb Pathog, 2018, 117: 148-152.
17
Mendy A, Forno E, Niyonsenga T, et al. Blood biomarkers as predictors of long-term mortality in COPD[J]. Clin Respir J,2018,12(5): 1891-1899.
18
Han S, Meng X. Prediction of risk for secondary lower respiratory tract fungal infection during the acute exacerbation phase of COPD[J]. J Infect Dev Ctries, 2023, 17(2): 268-275.
19
Yu YT, Liu J, Hu B, et al. Expert consensus on the use of human serum albumin in critically ill patients[J]. Chin Med J (Engl),2021, 134(14): 1639-1654.
20
Baumgartner A,Hasenboehler F,Cantone J,et al. Effect of nutritional support in patients with lower respiratory tract infection: Secondary analysis of a randomized clinical trial[J]. Clin Nutr,2021,40(4):1843-1850.
21
Prins HJ, Duijkers R, Daniels JMA, et al. COPD-lower respiratory tract infection visual analogue score (c-LRTI-VAS) validation in stable and exacerbated patients with COPD[J]. BMJ Open Respir Res, 2021, 8(1): e000761.
22
Drummond RA, Desai JV, Ricotta EE, et al. Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria[J]. Cell Host Microbe, 2022, 30(7): 1020-1033.
23
Jahan R, Mishra B, Behera B, et al. Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases[J]. Lung India, 2021, 38(1): 53-58.
24
Johnsen RH, Heerfordt CK, Boel JB, et al. Inhaled corticosteroids and risk of lower respiratory tract infection with Moraxella catarrhalis in patients with chronic obstructive pulmonary disease[J]. BMJ Open Respir Res, 2023, 10(1): e001726.
25
Pérez MA, Martínez L, Bravo J, et al. Infection due to Aspergillus flavus and Rhizopus oryzae complex in a patient with diabetes mellitus[J]. Biomedica, 2023, 43(1): 27-36.
26
Rafat Z, Hashemi SJ, Ashrafi K, et al. Fungal isolates of the respiratory tract in symptomatic patients hospitalized in pulmonary units: A mycological and molecular epidemiologic Study[J]. J Multidiscip Healthc, 2020, 13: 661-669.
27
Lao M, Li C, Li J, et al. Opportunistic invasive fungal disease in patients with type 2 diabetes mellitus from Southern China: Clinical features and associated factors[J]. J Diabetes Investig, 2020, 11(3): 731-744.
[1] 徐志刚, 曹涛, 何亭, 李博奥, 魏婧韬, 张栋梁, 官浩, 杨薛康. 采用抗生素骨水泥治疗糖尿病患者心脏术后胸骨骨髓炎的临床效果观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(06): 498-502.
[2] 姜珊, 李湘燕, 田硕涵, 温冰, 何睿, 齐心. 采用优化抗感染治疗模式改善糖尿病足感染预后的临床观察[J/OL]. 中华损伤与修复杂志(电子版), 2024, 19(05): 398-403.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 詹济玮, 蔡柳春, 温琼娜, 郭石生, 温春妹, 温鹤明. 布地格福联合噻托溴铵治疗AECOPD 的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 823-826.
[5] 刘璐璐, 何羽. 慢性阻塞性肺病患者睡眠障碍的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 836-839.
[6] 陈嘉艺, 陈佳, 张曦, 张琦. 伴有“反晕征”的IgG4 相关性肺疾病一例并文献复习[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 844-846.
[7] 王丹, 李文思, 成苏杭, 吉泽, 朱祥, 郝春艳. Treg/Th17 及DC 细胞水平在COPD不同疾病进展期的表达及其与预后的关系[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 685-689.
[8] 沈琪乐, 赵勤华, 宫素岗, 刘锦铭, 王岚, 邱宏玲. COPD 稳定期患者血清CC16 蛋白表达与肺功能、肺气肿表型的关系分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 690-695.
[9] 郭璟琪, 魏明言, 刘芳, 李冬凌, 关金平, 李立华. 乙酰半胱氨酸治疗慢性阻塞性肺疾病急性加重期的疗效分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 768-772.
[10] 赵小欢, 尚志英, 段文超, 张晓燕, 孙东强. 无创通气治疗COPD 并发呼吸衰竭不同预后患者外周血MicroRNA及炎性因子水平分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 777-780.
[11] 曹健, 冯高华, 周卫军, 陈诚, 沈王丰, 吴英姿. 补脾益肺膏联合肺康复训练治疗慢性阻塞性肺疾病的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 781-784.
[12] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 蔡晓雯, 李慧景, 丘婕, 杨翼帆, 吴素贤, 林玉彤, 何秋娜. 肝癌患者肝动脉化疗栓塞术后疼痛风险预测模型的构建及验证[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 722-728.
[15] 闫维, 张二明, 张克, 安欣华, 向平超. 北京市石景山区40岁及以上居民早期慢性阻塞性肺疾病异质性及影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 533-540.
阅读次数
全文


摘要